NMR-Based Lipidomic Analysis of Blood Lipoproteins Differentiates the Progression of Coronary Heart Disease
Author:
Affiliation:
1. Process Development, Shire, Lexington, Massachusetts United States
2. Laboratoire de Chimie-Physique Macromoléculaire, UMR 7568 CNRS-INPL, Nancy-Université, 1 Rue Grandville, B.P. 20451, 54001 Nancy Cedex, France
Publisher
American Chemical Society (ACS)
Subject
General Chemistry,Biochemistry
Link
https://pubs.acs.org/doi/pdf/10.1021/pr500061n
Reference58 articles.
1. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)
2. Novel and Conventional Biomarkers for Prediction of Incident Cardiovascular Events in the Community
3. Metabolomic Profiling for Identification of Novel Potential Biomarkers in Cardiovascular Diseases
4. Biomarkers for cardiovascular disease: challenges and future directions
Cited by 40 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Acute myocardial infarction preferentially alters low-abundant, long-chain unsaturated phospholipid and sphingolipid species in plasma high-density lipoprotein subpopulations;Atherosclerosis Plus;2024-03
2. Apolipoprotein B is associated with CT-angiographic progression beyond low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol in patients with coronary artery disease;Lipids in Health and Disease;2023-08-09
3. The benefits of measuring the size and number of lipoprotein particles for cardiovascular risk prediction: A systematic review and meta-analysis;Clínica e Investigación en Arteriosclerosis (English Edition);2023-07
4. Cardiometabolic disease risk markers are increased following burn injury in children;Frontiers in Public Health;2023-06-02
5. The Prospect of Genomic, Transcriptomic, Epigenetic and Metabolomic Biomarkers for The Personalized Prevention of Type 2 Diabetes and Cardiovascular Diseases;Current Vascular Pharmacology;2023-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3